Teva Slams Eli Lilly's 'Free Ride' On Migraine IP As Trial Opens

By Brian Dowling · October 19, 2022, 2:57 PM EDT

Teva Pharmaceuticals kicked off its migraine drug patent infringement trial against Eli Lilly and Co. on Wednesday, telling a Boston federal jury that the rival shouldn't be allowed to "free ride"...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Case Number

1:18-cv-12029

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 27, 2018